Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

The Pro and Cons of Law Latinib in Breast Cancer

Ross: I gave a strong argument against more latinib as the first line therapy but let's unpack some of the stuff that we we know and we don't know so all that there was a pretty amazing drug it has very good CNS penetration and it has this amazing results from crown. Ross: The most dramatic CNS efficacy of law latinib is in protecting the CNS that flat line is for people who don't have baseline brain metastases whereas if you look at the people who do have baseline brain metastases it still comes down. He says he'd also raise the idea that this may not just be because it's an alkinhibitor that gets into the brain

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app